CRISPR

CRISPR3-alx3

ID

ZDB-CRISPR-221003-1

Name

CRISPR3-alx3

Previous Names

None

Target

alx3 (1)

Sequence

5' - GGAGTCCCCAGTCAAGCCGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
uw2113	alx3

Expression

Gene expression in Wild Types + CRISPR3-alx3

No data available

Phenotype

Phenotype resulting from CRISPR3-alx3

No data available

Phenotype of all Fish created by or utilizing CRISPR3-alx3

Phenotype	Fish	Conditions	Figures
chondrocranium neural crest cell migration decreased process quality, abnormal	alx1^{uw2016/uw2016}; zf393Tg + CRISPR3-alx3	control	Fig. 6 from Yoon et al., 2022
eye col2a1a expression absent, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage col2a1a expression absent, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage decreased size, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
lateral ethmoid absent, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ventral mandibular arch protruding, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
eye nucleate erythrocyte increased distribution, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 3 from Yoon et al., 2022
eye morphology, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 3 from Yoon et al., 2022
chondrocranium shortened, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
chondrocranium col2a1a expression decreased distribution, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
lateral ethmoid decreased size, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage absent, abnormal	alx3^uw2113/+; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage col2a1a expression absent, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
eye morphology, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 3 from Yoon et al., 2022
eye col2a1a expression absent, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage decreased size, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
lateral ethmoid absent, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ventral mandibular arch protruding, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
eye nucleate erythrocyte increased distribution, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 3 from Yoon et al., 2022
chondrocranium shortened, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
ethmoid cartilage absent, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
chondrocranium col2a1a expression decreased distribution, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022
lateral ethmoid decreased size, abnormal	alx3^{uw2113/uw2113}; alx1^{uw2016/uw2016}	standard conditions	Fig. 2 from Yoon et al., 2022

Citations